| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |